AlphaSense Strengthens Its Life Sciences Platform

Clinical and commercial data is everywhere, but the signals that matter are scattered across trial registries, pipeline databases, regulatory sources, and competitive intelligence tools. That's why clinical, regulatory, and scientific data are now part of AlphaSense. Drug approvals, clinical trial registries, and patents and exclusivity data spanning the US, EU, and China now sit alongside AlphaSense's existing library of expert calls, broker research, and company documents. What that means for life sciences teams: - Ask in plain language, build a competitive landscape, or compare a pipeline - In an area like obesity, compare pipeline drugs by mechanism of action, modality, and indication, and see at a glance who's actually different - Identify buyout and licensing targets, choose the right trial endpoints, spot market gaps, or plan around loss of exclusivity - Every data point can be traced and validated, so decisions hold up under scrutiny - Select a citation to surface the underlying data, then filter down to exactly what matters Bring the full life sciences picture together in hours, not days, and see it clearly before the decision is in front of you. Learn more about how you can gain access here: https://www.alpha-sense.com/press/alphasense-strengthens-its-life-sciences-platform --- AlphaSense is a market intelligence and search platform used by the world’s leading companies and financial institutions. Learn more at https://www.alpha-sense.com